Literature DB >> 14499867

Right ventricular hypertrophy and apoptosis after pulmonary artery banding: regulation of PKC isozymes.

Martin U Braun1, Palma Szalai, Ruth H Strasser, Mathias M Borst.   

Abstract

OBJECTIVE: Pressure overload induced by pulmonary artery banding (PAB) leads to right ventricular (RV) hypertrophy and cardiomyocyte apoptosis. The present study was performed to investigate whether protein kinase C isozymes (PKC-alpha, PKC-betaI, PKC-betaII, PKC-delta and PFC- epsilon ), calcineurin and the renin-angiotensin system (RAS) contribute to PAB-induced cardiac remodeling. METHODS AND
RESULTS: PAB in male Wistar rats for 3 weeks results in enhanced PKC activity (as determined by ELISA assay) in the cytosol and membrane fraction of the hypertrophied RV, which was accompanied by increased expression (as determined by Western blot analysis) of cytosolic PKC-delta (+72%), PKC-alpha (+49%), and PKC-betaI (+39%), but not PKC-betaII and PKC- epsilon. This differential regulation of cardiac PKC isozymes was limited to the strained ventricle and was not altered in response to chronic angiotensin-converting enzyme inhibition with ramiprilate. Furthermore, no significant changes in the expression of calcineurin alpha and beta subunits were observed in RV pressure overload compared to controls. PAB-induced cardiac apoptosis was determined using Western blot analysis by a significantly increased expression of Bax protein and caspase-3 in the hypertrophied RV, which was diminished to almost control levels by chronic ramiprilate treatment. The myocardial expression of Bcl-2 was not significantly altered in the experimental groups.
CONCLUSION: We have shown for the first time that PAB-induced RV hypertrophy is associated with a differential regulation of cardiac PKC isozymes independent of the RAS and further provide evidence for a pivotal role of the RAS in the development of PAB-induced cardiac apoptosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14499867     DOI: 10.1016/s0008-6363(03)00470-x

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  20 in total

1.  Carvedilol inhibits right ventricular hypertrophy induced by chronic hypobaric hypoxia.

Authors:  L Tual; O-E Morel; F Favret; M Fouillit; C Guernier; A Buvry; L Germain; G Dhonneur; J-F Bernaudin; J-P Richalet
Journal:  Pflugers Arch       Date:  2006-04-26       Impact factor: 3.657

2.  Inhibition of anti-apoptotic signals by Wortmannin induces apoptosis in the remote myocardium after LAD ligation: evidence for a protein kinase C-δ-dependent pathway.

Authors:  Stephan Wiedemann; Teresa Wessela; Kerstin Schwarz; Dirk Joachim; Marcel Jercke; Ruth H Strasser; Bernd Ebner; Gregor Simonis
Journal:  Mol Cell Biochem       Date:  2012-09-27       Impact factor: 3.396

3.  Autophagy mechanism of right ventricular remodeling in murine model of pulmonary artery constriction.

Authors:  Natia Qipshidze; Neetu Tyagi; Naira Metreveli; David Lominadze; Suresh C Tyagi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-11-18       Impact factor: 4.733

4.  Dynamic microRNA expression during the transition from right ventricular hypertrophy to failure.

Authors:  Sushma Reddy; Mingming Zhao; Dong-Qing Hu; Giovanni Fajardo; Shijun Hu; Zhumur Ghosh; Viswanathan Rajagopalan; Joseph C Wu; Daniel Bernstein
Journal:  Physiol Genomics       Date:  2012-03-27       Impact factor: 3.107

5.  Bosentan attenuates right ventricular hypertrophy and fibrosis in normobaric hypoxia model of pulmonary hypertension.

Authors:  Gaurav Choudhary; Frederick Troncales; Douglas Martin; Elizabeth O Harrington; James R Klinger
Journal:  J Heart Lung Transplant       Date:  2011-05-08       Impact factor: 10.247

Review 6.  Surgical and physiological challenges in the development of left and right heart failure in rat models.

Authors:  Michael G Katz; Anthony S Fargnoli; Sarah M Gubara; Elena Chepurko; Charles R Bridges; Roger J Hajjar
Journal:  Heart Fail Rev       Date:  2019-09       Impact factor: 4.214

7.  Molecular and physiological characterization of RV remodeling in a murine model of pulmonary stenosis.

Authors:  Takashi Urashima; Mingming Zhao; Roger Wagner; Giovanni Fajardo; Sara Farahani; Tom Quertermous; Daniel Bernstein
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-27       Impact factor: 4.733

8.  Development of left ventricular diastolic dysfunction with preservation of ejection fraction during progression of infant right ventricular hypertrophy.

Authors:  Kazuo Kitahori; Huamei He; Mitsuhiro Kawata; Douglas B Cowan; Ingeborg Friehs; Pedro J Del Nido; Francis X McGowan
Journal:  Circ Heart Fail       Date:  2009-09-24       Impact factor: 8.790

9.  Reversal of right ventricular remodeling by dichloroacetate is related to inhibition of mitochondria-dependent apoptosis.

Authors:  Xiao-Qing Sun; Rui Zhang; Hong-Da Zhang; Ping Yuan; Xiao-Jian Wang; Qin-Hua Zhao; Lan Wang; Rong Jiang; Harm Jan Bogaard; Zhi-Cheng Jing
Journal:  Hypertens Res       Date:  2016-01-14       Impact factor: 3.872

10.  Nicorandil prevents right ventricular remodeling by inhibiting apoptosis and lowering pressure overload in rats with pulmonary arterial hypertension.

Authors:  Xiang-Rong Zuo; Qiang Wang; Quan Cao; Yan-Zhe Yu; Hui Wang; Li-Qing Bi; Wei-Ping Xie; Hong Wang
Journal:  PLoS One       Date:  2012-09-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.